NASDAQ:VRAX

Virax Biolabs Group Stock Forecast

etoro logo Buy VRAX
*Your capital is at risk
$2.88
-0.100 (-3.36%)
At Close: Aug 10, 2026

Should you buy VRAX stock?

Last updated:

Based on market data through , StockInvest.us rates Virax Biolabs Group Limited (VRAX) as a Sell Candidate with a technical score of -4.45 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Sell signal since
  • Price since signal Down 29.41%
  • 3-month trend forecast Down 34.14%
  • Sell Candidate -4.45
AI Analysis AI Analysis of VRAX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add VRAX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Monday for Virax Biolabs Group Limited stock after losing 3.36%
(Market data through Aug 10, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 10, 2026 Loss -29.41%

The Virax Biolabs Group Limited stock price fell by -3.36% on the last day (Monday, 10th Aug 2026) from $2.98 to $2.88. During the last trading day the stock fluctuated 7.17% from a day low at $2.79 to a day high of $2.99. The price has fallen in 6 of the last 10 days and is down by -7.1% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -25 thousand shares and in total, 34 thousand shares were bought and sold for approximately $99.22 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -34.14% during the next 3 months and, with a 90% probability hold a price between $0.494 and $3.60 at the end of this 3-month period.

VRAX Signals & Forecast

There are mixed signals in the stock today. The Virax Biolabs Group Limited stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.37. On a fall, the stock will find some support from the short-term average at $2.87. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, May 20, 2026, and so far it has fallen -63.89%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Virax Biolabs Group Limited stock

Virax Biolabs Group Limited finds support from accumulated volume at $2.77 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.200 between high and low, or 7.17%. For the last week the stock has had daily average volatility of 8.13%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VRAX) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Virax Biolabs Group Limited to open at $2.89, and during the day (based on 14 day Average True Range), to move between $2.61 and $3.15, which gives a possible trading interval of +/-$0.542 (+/-20.78%) up or down from last closing price. If Virax Biolabs Group Limited takes out the full calculated possible swing range there will be an estimated 20.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.94 (2.08%) than the support at $2.77 (3.82%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Virax Biolabs Group Limited stock A Buy?

Virax Biolabs Group Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.451 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $2.89 ( 0.231%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

VRAX Performance

Trading levels for VRAX

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.09 7.18%
R2 3.01 4.52%
R1 2.96 2.88%
Price 2.88
S1 2.81 -2.42%
S2 2.76 -4.06%
S3 2.69 -6.71%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.26 13.19%
R2 3.11 7.99%
R1 2.94 2.08%
Price 2.88
S1 2.77 -3.82%
S2 2.74 -4.86%
S3 2.62 -9.03%

FAQ

What is the symbol for Virax Biolabs Group Limited Stock and on which exchange is it traded?
The symbol for Virax Biolabs Group Limited is VRAX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Virax Biolabs Group Limited Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Virax Biolabs Group Limited (VRAX) as a Sell Candidate with a technical score of -4.45 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Sell signal began on Jul 10, 2026, the price has fallen 29.41%. The current 3-month trend forecast projects a fall of 34.14%.

How to buy Virax Biolabs Group Limited Stock?
Virax Biolabs Group Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Virax Biolabs Group Limited Stock.

What's the current price of Virax Biolabs Group Limited Stock?
As of the end of day on the Aug 10, 2026, the price of an Virax Biolabs Group Limited (VRAX) share was $2.88.

What is the 52-week high and low for Virax Biolabs Group Limited Stock?
The 52-week high for Virax Biolabs Group Limited Stock is $21.75 and the 52-week low is $2.50.

What is the market capitalization of Virax Biolabs Group Limited Stock?
As of the Aug 10, 2026, the market capitalization of Virax Biolabs Group Limited is 537.48K.

When is the next earnings date for Virax Biolabs Group Limited?
The upcoming earnings date for Virax Biolabs Group Limited is Dec 02, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE